Ms. Hawkins has been in the CRO industry since 1995 managing Phase 1-4 clinical trials across both EDC and paper platforms, including global, multilingual Phase 3-4 studies.
Her clinical research experience includes serving on EDC steering committees within several companies, application validation and serving as a point person for the implementation of the transition from paper based studies to EDC studies for several companies. She was an integral part of the Medrio implementation team at PharPoint Research and serves as a platform expert within the company. Ms. Hawkins’ extensive experience includes managing a multi-country, emergency use protocol, studies with special patient populations, and salvage therapy studies. Ms. Hawkins also has participated in industry related committees.